<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35743516</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Comprehensive Clinical Characterisation of Brain Fog in Adults Reporting Long COVID Symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3440</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11123440</ELocationID><Abstract><AbstractText>(1) Introduction: A subset of individuals experiencing long COVID symptoms are affected by 'brain fog', a lay term that often refers to general cognitive dysfunction but one that is still poorly characterised. In this study, a comprehensive clinical characterisation of self-reported brain fog was conducted vis-&#xe0;-vis other long COVID symptoms and parameters of mental, cognitive, and physical health. (2) Methodology: Adult participants reporting long COVID symptoms were recruited from hospital clinics and as self-referrals. Participants completed a battery of questionnaires and clinical assessments, including COVID-19 history, symptomatology, self-reported scales (Chalder Fatigue Scale [CFQ], Center for Epidemiological Studies Depression Scale, and Impact of Events Scale-Revised), computer-based cognitive assessments (simple response time and choice reaction time tasks), physical performance tests (gait velocity and muscle strength assessments), and an orthostatic active stand test. A systematic comparison between participants with and without self-reported brain fog was conducted, and a backwards binary logistic regression model was computed to identify the strongest independent associations with brain fog. This was complemented by an automatic cluster analysis to rank the importance of associations. Finally, a structural equation model was postulated with a causal model of key symptomatic indicators and functional consequences of brain fog as a latent variable. (3) Results: Of 108 participants assessed, brain fog was a self-reported symptom in 71 (65.7%) participants. Those with brain fog were at a longer point in time since COVID-19 onset and reported longer duration of low activity during the acute illness. When assessed, those with brain fog had higher frequencies of subjective memory impairment, word-finding difficulties, dizziness, myalgia, arthralgia, hyperhidrosis, cough, voice weakness, throat pain, visual and hearing problems, dysosmia, paraesthesia, chest pain, skin rashes, and hair loss; mean scores in fatigue, depression, and post-traumatic stress scales were higher; performance in both computer-based cognitive tasks was poorer; and measured gait speed and grip strength were lower. The logistic regression suggested that the best independent associations with brain fog were memory impairment, CFQ, and myalgia. The cluster analysis suggested that the most important associations with brain fog were CFQ, dizziness, myalgia, reduced gait speed, word-finding difficulties, reduced grip strength, and memory impairment. The SEM was consistent with key indicators of brain fog being CFQ, dizziness, myalgia, word-finding difficulties, and memory impairment; and reduced grip strength, gait speed, and cognitive response times its functional consequences. (4) Conclusions: The findings indicate that self-reported brain fog in long COVID is a recognisable symptom cluster primarily characterised by fatigue, dizziness, myalgia, word-finding difficulties, and memory impairment and has adverse psychological and psychomotor correlates. In long COVID, brain fog should be regarded as a wide-ranging symptom and addressed holistically with medical, psychological, and rehabilitative supports as guided by individual needs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jennings</LastName><ForeName>Glenn</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6243-6035</Identifier><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, D02 R590 Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaghan</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, D02 R590 Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, D02 R590 Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duggan</LastName><ForeName>Eoin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, D02 R590 Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mercer's Institute for Successful Ageing, St. James's Hospital, D08 N80H Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero-Ortu&#xf1;o</LastName><ForeName>Rom&#xe1;n</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3882-7447</Identifier><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, D02 R590 Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mercer's Institute for Successful Ageing, St. James's Hospital, D08 N80H Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute, Trinity College Dublin, D02 R590 Dublin, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>20/COV/8493</GrantID><Acronym>SFI_</Acronym><Agency>Science Foundation Ireland</Agency><Country>Ireland</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">gait</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neurocardiovascular assessment</Keyword><Keyword MajorTopicYN="N">neuropsychology</Keyword><Keyword MajorTopicYN="N">strength assessment</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35743516</ArticleId><ArticleId IdType="pmc">PMC9224578</ArticleId><ArticleId IdType="doi">10.3390/jcm11123440</ArticleId><ArticleId IdType="pii">jcm11123440</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cucinotta D., Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91:157&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation  WHO Coronavirus (COVID-19) Dashboard: World Health Organisation. 2021.  [(accessed on 7 April 2022)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Grant M.C., Geoghegan L., Arbyn M., Mohammed Z., McGuinness L., Clarke E.L., Wade R.G. The Prevalence of Symptoms in 24,410 Adults Infected by the Novel Coronavirus (SARS-CoV-2; COVID-19): A Systematic Review and Meta-Analysis of 148 Studies from 9 Countries. PLoS ONE. 2020;15:e0234765. doi: 10.1371/journal.pone.0234765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0234765</ArticleId><ArticleId IdType="pmc">PMC7310678</ArticleId><ArticleId IdType="pubmed">32574165</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation  A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. 2021.  [(accessed on 7 April 2022)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings G., Monaghan A., Xue F., Mockler D., Romero-Ortu&#xf1;o R. A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome. J. Clin. Med. 2021;10:5913. doi: 10.3390/jcm10245913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245913</ArticleId><ArticleId IdType="pmc">PMC8708187</ArticleId><ArticleId IdType="pubmed">34945213</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Ortu&#xf1;o R., Jennings G., Xue F., Duggan E., Gormley J., Monaghan A. Predictors of Submaximal Exercise Test Attainment in Adults Reporting Long COVID Symptoms. J. Clin. Med. 2022;11:2376. doi: 10.3390/jcm11092376.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11092376</ArticleId><ArticleId IdType="pmc">PMC9099491</ArticleId><ArticleId IdType="pubmed">35566502</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent Fatigue Following SARS-CoV-2 Infection Is Common and Independent of Severity of Initial Infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Long COVID Syndrome-Associated Brain Fog. J. Med. Virol. 2021;94:979&#x2013;984. doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross A.J., Medow M.S., Rowe P.C., Stewart J.M. What is Brain Fog? An Evaluation of the Symptom in Postural Tachycardia Syndrome. Clin. Auton. Res. 2013;23:305&#x2013;311. doi: 10.1007/s10286-013-0212-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-013-0212-z</ArticleId><ArticleId IdType="pmc">PMC3896080</ArticleId><ArticleId IdType="pubmed">23999934</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocon A.J. Caught in the Thickness of Brain Fog: Exploring the Cognitive Symptoms of Chronic Fatigue Syndrome. Front. Physiol. 2013;4:63. doi: 10.3389/fphys.2013.00063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2013.00063</ArticleId><ArticleId IdType="pmc">PMC3617392</ArticleId><ArticleId IdType="pubmed">23576989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail Z., Elbayoumi H., Fischer C.E., Hogan D.B., Millikin C.P., Schweizer T., Mortby M.E., Smith E.E., Patten S.B., Fiest K.M. Prevalence of Depression in Patients With Mild Cognitive Impairment. JAMA Psychiatry. 2017;74:58&#x2013;67. doi: 10.1001/jamapsychiatry.2016.3162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2016.3162</ArticleId><ArticleId IdType="pubmed">27893026</ArticleId></ArticleIdList></Reference><Reference><Citation>Musella A., Gentile A., Rizzo F.R., De Vito F., Fresegna D., Bullitta S., Vanni V., Guadalupi L., Bassi S.M., Buttari F., et al. Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions. Front. Aging Neurosci. 2018;10:238. doi: 10.3389/fnagi.2018.00238.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00238</ArticleId><ArticleId IdType="pmc">PMC6092506</ArticleId><ArticleId IdType="pubmed">30135651</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C. The Chalder Fatigue Scale (CFQ 11) Occup. Med. 2014;65:86. doi: 10.1093/occmed/kqu168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqu168</ArticleId><ArticleId IdType="pubmed">25559796</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton W.W., Smith C., Ybarra M., Muntaner C., Tien A. Center for Epidemiologic Studies Depression Scale: Review and Revision (CESD and CESD-R) In: Maruish M.E., editor. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment: Instruments for Adults. Lawrence Erlbaum Associates Publishers; Mahwah, NJ, USA: 2004. pp. 363&#x2013;377.</Citation></Reference><Reference><Citation>Hyer K., Brown L. The Impact of Event Scale&#x2014;Revised: A Quick Measure of a Patient&#x2019;s Response to Trauma. Am. J. Nurs. Sci. 2008;108:60&#x2013;68. doi: 10.1097/01.NAJ.0000339101.39986.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.NAJ.0000339101.39986.85</ArticleId><ArticleId IdType="pubmed">18946269</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoet G. PsyToolkit: A software package for programming psychological experiments using Linux. Behav. Res. Methods. 2010;42:1096&#x2013;1104. doi: 10.3758/BRM.42.4.1096.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/BRM.42.4.1096</ArticleId><ArticleId IdType="pubmed">21139177</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane C., Van Wijnen V.K., Fan C.W., Soraghan C., Byrne L., Westerhof B.E., Freeman R., Fedorowski A., Harms M.P., Wieling W., et al. A Practical Guide to Active Stand Testing and Analysis using Continuous Beat-to-Beat Non-Invasive Blood Pressure Monitoring. Clin. Auton. Res. 2019;29:427&#x2013;441. doi: 10.1007/s10286-019-00606-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-019-00606-y</ArticleId><ArticleId IdType="pubmed">31076939</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaghan A., Jennings G., Xue F., Byrne L., Duggan E., Romero-Ortu&#xf1;o R. Orthostatic Intolerance in Adults Reporting Long COVID Symptoms was not Associated with Postural Orthostatic Tachycardia Syndrome. Front. Physiol. 2022;13:833650. doi: 10.3389/fphys.2022.833650.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.833650</ArticleId><ArticleId IdType="pmc">PMC8931464</ArticleId><ArticleId IdType="pubmed">35309052</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue F., Monaghan A., Jennings G., Byrne L., Foran T., Duggan E., Romero-Ortu&#xf1;o R. A Novel Methodology for the Synchronous Collection and Multimodal Visualization of Continuous Neurocardiovascular and Neuromuscular Physiological Data in Adults with Long COVID. Sensors. 2022;22:1758. doi: 10.3390/s22051758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s22051758</ArticleId><ArticleId IdType="pmc">PMC8914998</ArticleId><ArticleId IdType="pubmed">35270905</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa Rodr&#xed;guez P., Mart&#xed;nez Aguilar A., Ripoll Mu&#xf1;oz M.P., Rodr&#xed;guez Navarro M.&#xc1;. Long COVID: Is it really myalgic encephalomyelitis? Bibliographic review and considerations. Semergen. 2022;48:63&#x2013;69. doi: 10.1016/j.semerg.2021.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semerg.2021.03.006</ArticleId><ArticleId IdType="pmc">PMC8437705</ArticleId><ArticleId IdType="pubmed">34531126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome: A systemic review and comparison of clinical presentation and symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: A narrative review. Ther. Adv. Infect. Dis. 2021;8:20499361211009385. doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of post-acute COVID-19 syndrome. Trends Mol. Med. 2021;27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebaiti M.A., Hainselin M., Gouden Y., Sirbu C.A., Sekulic S., Lorusso L., Nacul L., Authier F.J. Systematic review and meta-analysis of cognitive impairment in myalgic encephalomyelitis/chronic fatigue syndrome. Sci. Rep. 2022;12:2157. doi: 10.1038/s41598-021-04764-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-04764-w</ArticleId><ArticleId IdType="pmc">PMC8828740</ArticleId><ArticleId IdType="pubmed">35140252</ArticleId></ArticleIdList></Reference><Reference><Citation>Attree E.A., Arroll M.A., Dancey C.P., Griffith C., Bansal A.S. Psychosocial factors involved in memory and cognitive failures in people with myalgic encephalomyelitis/chronic fatigue syndrome. Psychol. Res. Behav. Manag. 2014;7:67&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3940708</ArticleId><ArticleId IdType="pubmed">24596470</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt J., Blease C., Geraghty K.J. Long Covid at the crossroads: Comparisons and lessons from the treatment of patients with myalgic encephalomyelitis/chronic fatigue syndrome. J. Health Psychol. 2022;27:13591053221084494. doi: 10.1177/13591053221084494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13591053221084494</ArticleId><ArticleId IdType="pubmed">35341334</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., Jolly A.E., Grant J.E., Patrick F., Mazibuko N., Williams S.C., Barnby J.M., Hellyer P., et al. Cognitive Deficits in People who have Recovered from COVID-19. eClinicalMedicine. 2021;39:e101044. doi: 10.1016/j.eclinm.2021.101044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Gabriel U., Gygax P. Testing the Effectiveness of the Internet-Based Instrument PsyToolkit: A Comparison between Web-Based (PsyToolkit) and Lab-Based (E-Prime 3.0) Measurements of Response Choice and Response Time in a Complex Psycholinguistic Task. PLoS ONE. 2019;14:e0221802. doi: 10.1371/journal.pone.0221802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0221802</ArticleId><ArticleId IdType="pmc">PMC6726137</ArticleId><ArticleId IdType="pubmed">31483826</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G., Goldoni M., Solinas E., Cavalli C., Tagliaferri S., Ranzieri S., Frizzelli A., Marchi L., Mori P.A., Majori M., et al. Sex-Related Differences in Long-COVID-19 Syndrome. J. Women&#x2019;s Health. 2022;31:620&#x2013;630. doi: 10.1089/jwh.2021.0411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2021.0411</ArticleId><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>Thelle D.S., Laake P. Epidemiology. In: Laake P., Benestad H.B., Olsen B.R., editors. Planning and Preparation to Grant Application and Publication. Academic Press; Cambridge, MA, USA: 2015. pp. 275&#x2013;320.</Citation></Reference><Reference><Citation>Hess A.S., Abd-Elsayed A. Observational Studies: Uses and Limitations. In: Abd-Elsayed A., editor. Pain. Springer; Berlin/Heidelberg, Germany: 2019. pp. 123&#x2013;125.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>